Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours
This study is currently recruiting participants.
Study NCT00353496   Information provided by Ipsen
First Received: July 17, 2006   Last Updated: August 27, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Endocrine Tumors
Additional conditions recognized in this trial
Adenoma, Islet Cell
Endocrine Gland Neoplasms
More general conditions related to this trial
Adenoma
Digestive System Diseases
Digestive System Neoplasms
Endocrine System Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Pancreatic Diseases
Pancreatic Neoplasms
Interventions listed in this trial
lanreotide (Autogel formulation)
Placebo
Additional drug interventions recognized in this trial
Angiopeptin
Lanreotide
More general drug interventions related to this trial
Antineoplastic Agents
Cardiovascular Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Ipsen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services